CI
NYSE · Health Care
The Cigna Group
$288.06
+4.02 (+1.42%)
Financial Highlights (FY 2026)
Revenue
268.23B
Net Income
5.81B
Gross Margin
9.3%
Profit Margin
2.2%
Rev Growth
+15.1%
D/E Ratio
0.75
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 9.3% | 9.3% | 67.3% | 67.3% |
| Operating Margin | 3.3% | 3.0% | 20.0% | 21.4% |
| Profit Margin | 2.2% | 2.1% | 18.4% | 16.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 268.23B | 233.14B | 20.79B | 19.67B |
| Gross Profit | 24.95B | 21.68B | 13.98B | 13.23B |
| Operating Income | 8.99B | 7.03B | 4.15B | 4.22B |
| Net Income | 5.81B | 4.55B | 3.82B | 3.23B |
| Gross Margin | 9.3% | 9.3% | 67.3% | 67.3% |
| Operating Margin | 3.3% | 3.0% | 20.0% | 21.4% |
| Profit Margin | 2.2% | 2.1% | 18.4% | 16.4% |
| Rev Growth | +15.1% | +15.1% | +10.3% | -7.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 16.23B | 16.23B | 9.64B | 10.69B |
| Total Equity | 21.51B | 21.51B | 39.82B | 40.31B |
| D/E Ratio | 0.75 | 0.75 | 0.24 | 0.27 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 10.69B | 8.83B | 5.23B | 4.95B |
| Free Cash Flow | — | — | 3.42B | 2.15B |